171 related articles for article (PubMed ID: 38353903)
21. Combined Dextran-Graft-Polyacrylamide/Zinc Oxide Nanocarrier for Effective Anticancer Therapy in vitro.
Chumachenko V; Virych P; Nie G; Virych P; Yeshchenko O; Khort P; Tkachenko A; Prokopiuk V; Lukianova N; Zadvornyi T; Rawiso M; Ding L; Kutsevol N
Int J Nanomedicine; 2023; 18():4821-4838. PubMed ID: 37662686
[TBL] [Abstract][Full Text] [Related]
22. Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231).
Kc B; Paudel SN; Rayamajhi S; Karna D; Adhikari S; Shrestha BG; Bisht G
Chem Cent J; 2016; 10():16. PubMed ID: 27042206
[TBL] [Abstract][Full Text] [Related]
23. Desertifilum sp. EAZ03 cell extract as a novel natural source for the biosynthesis of zinc oxide nanoparticles and antibacterial, anticancer and antibiofilm characteristics of synthesized zinc oxide nanoparticles.
Ebadi M; Zolfaghari MR; Aghaei SS; Zargar M; Noghabi KA
J Appl Microbiol; 2022 Jan; 132(1):221-236. PubMed ID: 34101961
[TBL] [Abstract][Full Text] [Related]
24. Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent.
Wiesmann N; Kluenker M; Demuth P; Brenner W; Tremel W; Brieger J
J Trace Elem Med Biol; 2019 Jan; 51():226-234. PubMed ID: 30115501
[TBL] [Abstract][Full Text] [Related]
25. ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells.
Dumontel B; Susa F; Limongi T; Canta M; Racca L; Chiodoni A; Garino N; Chiabotto G; Centomo ML; Pignochino Y; Cauda V
Nanomedicine (Lond); 2019 Nov; 14(21):2815-2833. PubMed ID: 31747855
[No Abstract] [Full Text] [Related]
26. Live bio-nano-sonosensitizer targets malignant tumors in synergistic therapy.
Yin C; Li Y; Liao Z; Wang Z; Dai C; Wang W; Yang E; Guo F; Wright IR; Martin LL; Sun D
Acta Biomater; 2023 Jan; 155():491-506. PubMed ID: 36427685
[TBL] [Abstract][Full Text] [Related]
27. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
28. Concanavalin A receptors on the surface membrane of lymphocytes from patients with African Burkitt's lymphoma and lymphoma cell lines.
Ben-Bassat H; Goldblum N; Mitrani S; Klein G; Johansson B
Int J Cancer; 1976 Apr; 17(4):448-54. PubMed ID: 1279037
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
30. Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.
Li L; Xing H; Zhang J; Lu Y
Acc Chem Res; 2019 Sep; 52(9):2415-2426. PubMed ID: 31411853
[TBL] [Abstract][Full Text] [Related]
31. Dye-doped biodegradable nanoparticle SiO
Navarro-Palomares E; González-Saiz P; Renero-Lecuna C; Martín-Rodríguez R; Aguado F; González-Alonso D; Fernández Barquín L; González J; Bañobre-López M; Fanarraga ML; Valiente R
Nanoscale; 2020 Mar; 12(10):6164-6175. PubMed ID: 32133463
[TBL] [Abstract][Full Text] [Related]
32. Synergistic biocidal effects of metal oxide nanoparticles-assisted ultrasound irradiation: Antimicrobial sonodynamic therapy against Streptococcus mutans biofilms.
Pourhajibagher M; Bahador A
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102432. PubMed ID: 34246828
[TBL] [Abstract][Full Text] [Related]
33. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells.
Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K
Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139
[TBL] [Abstract][Full Text] [Related]
34. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
Hu T; Gao Y
Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
[TBL] [Abstract][Full Text] [Related]
35. Smart Shockwave Responsive Titania-Based Nanoparticles for Cancer Treatment.
Vighetto V; Racca L; Canta M; Matos JC; Dumontel B; Gonçalves MC; Cauda V
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575499
[TBL] [Abstract][Full Text] [Related]
36. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
37. The Antimicrobial Peptide, Nisin, Synergistically Enhances the Cytotoxic and Apoptotic Effects of Rituximab Treatment on Human Burkitt's Lymphoma Cell Lines.
Mohammadi P; Zangeneh M; Mohammadi-Motlagh HR; Khademi F
Rep Biochem Mol Biol; 2020 Oct; 9(3):250-256. PubMed ID: 33649717
[TBL] [Abstract][Full Text] [Related]
38. Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt's lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib.
Jeong Y; Kim SB; Yang CE; Yu MS; Choi WS; Jeon Y; Lim JY
Front Oncol; 2023; 13():1252658. PubMed ID: 37752998
[TBL] [Abstract][Full Text] [Related]
39. HDAC-selective Inhibitor Cay10603 Has Single Anti-tumour Effect in Burkitt's Lymphoma Cells by Impeding the Cell Cycle.
Ma XJ; Xu G; Li ZJ; Chen F; Wu D; Miao JN; Zhan Y; Fan Y
Curr Med Sci; 2019 Apr; 39(2):228-236. PubMed ID: 31016515
[TBL] [Abstract][Full Text] [Related]
40. Comparison Study of Cytotoxicity of Bare and Functionalized Zinc Oxide Nanoparticles.
Król-Górniak A; Rafińska K; Monedeiro F; Pomastowski P; Buszewski B
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
